Kintara Therapeutics, Inc. (KTRA)

NASDAQ: KTRA · IEX Real-Time Price · USD

0.259

-0.038 (-12.91%)

At close: Jul 2, 2024, 4:00 PM

0.268

+0.009 (3.40%)

After-hours: Jul 2, 2024, 7:59 PM EDT

Kintara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	Current	2023	2022	2021	2020	2019	2018 - 2011
Market Capitalization	14	7	18	74	8	3	Upgrade
Market Cap Growth	-31.33%	-62.57%	-75.40%	841.90%	129.78%	-77.24%	Upgrade
Enterprise Value	8	5	6	64	5	-0	Upgrade
PE Ratio	-	-0.45	-0.72	-1.78	-0.86	-0.42	Upgrade
PB Ratio	2.42	9.33	1.55	7.00	29.89	1.74	Upgrade
P/FCF Ratio	-0.56	-0.56	-0.89	-3.92	-0.99	-0.54	Upgrade
P/OCF Ratio	-0.56	-0.57	-0.89	-3.93	-0.99	-0.54	Upgrade
EV/EBITDA Ratio	0.24	-0.36	-0.28	-1.66	-0.60	0.04	Upgrade
EV/EBIT Ratio	0.24	-0.36	-0.28	-1.66	-0.59	0.04	Upgrade
EV/FCF Ratio	0.32	-0.44	-0.32	-3.37	-0.69	0.05	Upgrade
Quick Ratio	4.74	0.50	2.95	3.79	0.89	1.80	Upgrade
Current Ratio	5.04	1.06	3.32	4.24	1.07	1.95	Upgrade
Interest Coverage	-	-	-	-1472.00	-	-	Upgrade
Return on Equity (ROE)	-852.50%	-289.80%	-184.60%	-256.00%	-221.80%	-336.40%	Upgrade
Return on Assets (ROA)	-257.30%	-177.50%	-146.10%	-218.40%	-159.60%	-212.80%	Upgrade
Return on Capital (ROIC)	-158.98%	-2024.08%	-192.30%	-360.70%	-3497.34%	-426.85%	Upgrade
Earnings Yield	-66.38%	-220.24%	-137.95%	-56.05%	-116.31%	-237.60%	Upgrade
FCF Yield	-50.68%	-177.39%	-111.93%	-25.48%	-100.85%	-184.95%	Upgrade
Buyback Yield / Dilution	-2550.92%	-66.32%	-88.13%	-147.86%	-305.64%	-23.42%	Upgrade
Total Shareholder Return	-2550.92%	-66.32%	-88.13%	-147.86%	-305.64%	-23.42%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).